![Joshua Brumm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joshua Brumm
Voorzitter bij Amphista Therapeutics Ltd.
Vermogen: 767 830 $ op 31-05-2024
Actieve functies van Joshua Brumm
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Amphista Therapeutics Ltd.
![]() Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Voorzitter | 21-09-2021 | - |
Independent Dir/Board Member | 21-09-2021 | - | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Adviseur | - | - |
Loopbaan van Joshua Brumm
Eerdere bekende functies van Joshua Brumm
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DYNE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-10-2019 | 25-03-2024 |
Algemeen Directeur | 01-10-2019 | 25-03-2024 | |
President | 01-10-2019 | 25-03-2024 | |
Bedrijfssecretaris | 01-10-2019 | 25-03-2024 | |
KALEIDO BIOSCIENCES, INC. | Operationeel Directeur | 01-08-2018 | 11-10-2019 |
Financieel Directeur/CFO | 01-08-2018 | 11-10-2019 | |
ARAVIVE, INC. | Operationeel Directeur | 01-11-2013 | 31-12-2017 |
Financieel Directeur/CFO | 01-11-2013 | 31-12-2017 | |
Versartis, Inc.
![]() Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Operationeel Directeur | 27-01-2017 | 01-12-2017 |
Financieel Directeur/CFO | 07-01-2014 | 01-12-2017 | |
Public Communications Contact | - | 01-12-2017 | |
PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | 25-10-2012 | 14-08-2013 |
Financieel Directeur/CFO | 25-10-2012 | 14-08-2013 | |
ZELTIQ AESTHETICS INC | Financieel Directeur/CFO | 01-12-2009 | 08-08-2012 |
Investor Relations Contact | 28-11-2011 | 08-08-2012 | |
Public Communications Contact | 28-11-2011 | 08-08-2012 | |
Corporate Officer/Principal | 18-07-2011 | 28-11-2011 | |
Verkoop & Marketing | 01-03-2011 | 18-07-2011 | |
Proteolix, Inc.
![]() Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Financieel Directeur/CFO | 01-12-2009 | 01-12-2009 |
░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Joshua Brumm
University of Notre Dame | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Verenigd Koninkrijk | 2 |
Operationeel
Director of Finance/CFO | 6 |
Chief Operating Officer | 3 |
Public Communications Contact | 2 |
Sectoraal
Health Technology | 9 |
Consumer Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
KALEIDO BIOSCIENCES, INC. | Health Technology |
DYNE THERAPEUTICS, INC. | Health Technology |
ARAVIVE, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
ZELTIQ Aesthetics, Inc.
![]() ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Proteolix, Inc.
![]() Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Pharmacyclics LLC
![]() Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Versartis, Inc.
![]() Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Amphista Therapeutics Ltd.
![]() Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Health Technology |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Water Street Solutions, Inc.
![]() Water Street Solutions, Inc. Water UtilitiesUtilities Part of Advanced Water Recovery, Water Street Solutions, Inc. provides industrial water and wastewater treatment systems and services. The company is based in Peoria, IL. Water Street Solutions was acquired by Advanced Water Recovery on February 01, 2014. | Utilities |
- Beurs
- Insiders
- Joshua Brumm
- Ervaring